Nickel (Ni) is the most frequent metal allergen and induces Th1-dependent type-IV allergies. In local skin, epidermal Langerhans cells (Lcs) and/or dermal dendritic cells (Dcs) uptake antigens and migrate to draining lymph nodes (LNs). However, the subsets of antigen-presenting cells that contribute to Ni presentation have not yet been identified. In this study, we analyzed the Ni-binding capabilities of murine DCs using fluorescent metal indicator Newport Green. Elicitation of Ni allergy was assessed after intradermal (i.d.) injection of Ni-treated DCs into ear pinnae of Ni-sensitized mice. The Ni-binding capabilities of MHC class II hi CD11c int migratory DCs were significantly stronger than those of MHC class ii int CD11c hi resident DCs and CD11c int PDCA1 + MHC class II int B220 + plasmacytoid DCs. Migratory DCs in skin-draining and mandibular LNs showed significantly stronger Ni-binding capabilities than those in mesenteric and medial iliac LNs. An i.d. injection of IL-1β induced the activation of Lcs and dermal Dcs with strong Ni-binding capabilities. Ni-binding LCs were detected in draining LNs after i.d. challenge with IL-1β and Ni. Moreover, an i.d. injection of Ni-treated DCs purified from skin-draining LNs elicited Ni-allergic inflammation. These results demonstrated that migratory DCs in skin-draining LNs have strong Ni-binding capabilities and elicit Ni allergy.
activators of transcription pathways, and promotes Th17 cells 17 . Ni ions have been shown to stimulate human Toll-like receptor 4, but not its murine homolog 18 . In a murine model, Ni induced the activation of NF-κB and activator protein-1 in mouse fetal skin-derived DCs 19 . Bone marrow-derived DCs were also shown to be stimulated with Ni through the MAPK pathway 20 . These findings indicate that Ni ions stimulate human and murine DCs. However, the subsets of DCs that respond to Ni have not yet been identified.
Metal ions are considered to function as haptens, which bind to self-protein(s) and induce conformational changes. Serum albumin is a well-known metal-binding protein 21 . We reported recently that the C-X-C motif chemokine CXCL4 is a novel Ni-binding protein and augments Ni allergy at the sensitization and elicitation phases 22 . However, the underlying mechanisms by which metal ions are recognized by the immune system remain unclear.
The aim of the present study was to identify which DC subsets are responsible for Ni presentation. To achieve this, we used Newport Green (NPG), a fluorescent metal probe that specifically binds to Ni ions 23 . We examined the Ni-binding capability of APCs in regional LNs and local skin tissues. We demonstrated that migratory DCs in skin-draining and mandibular LNs exhibited strong Ni-binding capabilities. An intradermal (i.d.) injection of IL-1β, an inflammatory cytokine that plays a role in Ni allergy 24 , induced the activation of epidermal LCs and dermal DCs with strong Ni-binding capabilities. Furthermore, we showed that Ni-treated DCs from skin-draining LNs elicited Ni-allergic inflammation.
Results
Migratory DCs in skin-draining LNs bind to Ni. We assessed the Ni-binding capabilities of DCs in skin-draining LNs. Skin-draining LN cells contained three DC subsets: MHC class II hi CD11c int migratory DCs, MHC class II int CD11c hi resident DCs, and CD11c int PDCA1 + MHC class II int B220 + pDCs (Fig. 1a ). LN cells were incubated with various concentration of Ni for 60 min, then stained with NPG. The mean fluorescence intensity (MFI) of NPG increased in a Ni dose-dependent manner (Fig. 1b ). Migratory DCs showed significantly higher MFI with 100 μM Ni than those of control (0 μM Ni). When LN cells were incubated with 100 μM Ni for the indicated time, MFI gradually increased in an incubation time-dependent manner and reached plateau at 60 min (Fig. 1c ). The MFI was significantly higher in migratory DCs than in resident DCs and pDCs, regardless of Ni concentrations or incubation time. On the other hand, macrophages, B220 + B cells, CD4 + and CD8 + T cells exhibited significantly weaker Ni-binding capabilities than those of the migratory DCs ( Fig. 1d and Supplementary Fig. S1 ). These results indicated that migratory DCs, but not resident DCs or pDCs specifically bound to Ni. Incubation with 100 μM Ni for 60 min was used, and Ni-binding capabilities were shown as ΔMFI, calculated as [MFI Ni 100 μM -MFI Ni 0 μM ] in subsequent experiments.
The biochemical properties of Ni-binding capabilities were also analyzed. ΔMFI was significantly decreased by the treatment with EDTA before NPG staining ( Fig. 2a ), indicating that Ni binding was reversible and removed by chelating. Whether divalent cations compete with the Ni binding was also analyzed. No significant changes in ΔMFI were detected in the presence of the other divalent cations, Ca 2+ , Mn 2+ ,and Co 2+ (Fig. 2b) . Palladium ions show cross-reactivity with Ni 25 . However, due to high cytotoxicity, it was not possible to test Pd 2+ . ΔMFI was not decreased by trypsin-treatment ( Fig. 2c ), indicating that Ni-binding capabilities were trypsin resistant. The MFI of MHC class II increased significantly with trypsin treatment. On the other hand, the MFI of CD11c was trypsin-sensitive. We analyzed whether MHC class II is involved in the Ni-binding capabilities of migratory DCs in skin-draining LNs. Cells were preincubated with two kinds of anti-MHC class II mAbs, anti-I-A/I-E clone M5/114.15.2 and anti-I-A b clone AF6-120.1, before incubation with Ni ions. However, neither of these Abs affected ΔMFI ( Fig. 2d ).
Ni-binding capabilities differ between draining LNs. Because Ni allergies mainly develop skin inflam-
mation, we analyzed the Ni-binding capabilities of migratory and resident DCs in other LNs. Supplementary  Fig. S2 shows the gating strategy of skin-draining, mandibular, mesenteric, and medial iliac LNs and the spleen. All LNs have migratory and resident DCs, whereas the spleen has only resident DCs. No XCR1 − EpCAM + LC was detected in the migratory DCs of mesenteric and medial iliac LNs. Because of lower events, it was not possible to analyze XCR1 + cDC1 and XCR1 − EpCAM − CD11b − DNcDC in medial iliac LNs. All four subsets, XCR1 + cDC1, XCR1 − EpCAM − CD11b + cDC2, XCR1 − EpCAM − CD11b − DNcDC and XCR1 − EpCAM + LC of migratory DCs exhibited strong Ni-binding capabilities in skin-draining and mandibular LNs (Fig. 3a,b ). On the other hand, those in mesenteric LNs showed significantly weaker Ni-binding capabilities. The Ni-binding capabilities of migratory DCs in medial iliac LNs was significantly weaker than those of skin-draining and mandibular LNs, but significantly stronger than those of mesenteric LNs. Resident DCs in all LNs and the spleen exhibited weak Ni-binding capabilities (Fig. 3a,c) . These results indicated that migratory DCs in skin-draining and mandibular LNs have strong Ni-binding capabilities.
IL-1β induces MHC class II hi cells with strong Ni-binding capabilities in ear pinnae. Ni-binding
capabilities of APCs in local skin tissues were also analyzed. We hypothesized that inflammatory mediator(s) affects the Ni-binding capabilities. IL-1β is a critical inflammatory cytokine for Ni allergy and well-known activator of MHC class II + APCs 24, 26 . Therefore, we investigated the effects of IL-1β on the Ni-binding capabilities of APCs in ear pinnae. A flow cytometric analysis identified CD45 + CD207 + MHC class II + epidermal LCs and CD45 + MHC class II + CD11c + dermal DCs in the epidermis and dermis, respectively ( Fig. 4a,b ). An i.d. injection of IL-1β significantly induced MHC class II hi cells in LCs and dermal DCs. The percentage of MHC class II hi cells was more than 10-fold higher in IL-1β-injected ear pinnae than in control PBS-injected ear pinnae ( Fig. 4c ). LCs divided NPG lo and NPG hi , even in the absence of Ni, indicating that NPG hi is non-specific NPG binding. Therefore, we examined the MFI of NPG lo cells. Ni-binding capabilities were stronger in MHC class II hi cells than in MHC class II int cells, whereas no significant differences were observed between IL-1β-and PBS-injected ear In vivo challenge with Ni induced Ni-binding LCs in draining LNs. We assessed whether an in vivo challenge induced Ni-binding DCs in draining LNs. Ear pinnae of naïve mice were i.d. challenged 5 times every 24 h with 50 ng of IL-1β in the presence or absence of 10 mM NiCl 2 . Twenty-four hours after the last challenge, cells from the draining LNs were stained with NPG in the absence of in vitro incubation with Ni. The MFI of NPG was significantly higher in LCs from the LNs challenged with IL-1β and Ni compared with IL-1β alone (Fig. 5 ). These results indicated that Ni-binding APCs were detected after an in vivo challenge with Ni. Induction of IL-1β in pan-DCs stimulated with Ni. We investigated whether Ni stimulation induced the expression of inflammatory cytokines. Due to the low cell number of DCs in LNs, we tried to expand the cell number of DCs in vivo. To achieve this, mice were s.c. injected B16 melanoma cells constitutively secreting Flt3 ligand (referred as B16-Flt3L) cells and LNs were collected 2 weeks after injection. Flt3L is a critical cytokine in DC-development 27 . Moreover, we sorted a pan-DC fraction from LNs and performed further experiments using www.nature.com/scientificreports www.nature.com/scientificreports/ these cells. The gating strategies of the skin-draining and mesenteric LN cells and pan-DC fraction from mice with B16-Flt3L are shown ( Supplementary Figs. S3a-d ). Ni-binding capabilities were stronger in migratory DCs of skin-draining LNs than other DCs in the same way as those from mice without B16-Flt3L ( Supplementary  Figs . S3e,f). Stimulation with 1,000 μM Ni for 4 h induced significantly higher expression levels of IL-1β mRNA in pan-DCs from skin-draining and mesenteric LNs (Fig. 6a ). On the other hand, the mRNA expression levels of TNFα were increased significantly by stimulation with LPS but not Ni ( Supplementary Fig. S4 ). Protein expression levels of intracellular pro-IL-1β were also analyzed. Cells were incubated with each stimuli for 4 h, then further incubated for 20 h without any stimulation. Significantly higher expression levels of intracellular pro-IL-1β were detected in MHC class II + CD11c + cells stimulated with 1,000 μM Ni or LPS for 24 h (Fig. 6b,c) . These results indicated that Ni stimulation induced the expression of IL-1β. 
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Pan-DCs were incubated with 100 μM Ni or PBS for 60 min (referred to as Ni-DCs and PBS-DCs, respectively), then i.d. injected into the ear pinnae of Ni-sensitized mice. Ni-DCs prepared from skin-draining LNs induced significantly greater ear swelling after i.d. injection ( Fig. 7c and Supplementary Fig. S5b ). However, the i.d. injection of Ni-DCs prepared from the mesenteric LNs did not induce ear swelling, even though donor cells were detected in the migratory DC fraction of auricular LNs in recipient mice (Fig. 7a-c) . The i.d. injection of PBS-DCs prepared from the skin-draining and mesenteric LNs did not induced ear swelling. No ear swelling was induced in non-sensitized mice after i.d. injection with Ni-DCs prepared from skin-draining LNs (Fig. 7d) , indicating that this ear swelling was an allergic, but not inflammatory, response. As reported previously 22 , no www.nature.com/scientificreports www.nature.com/scientificreports/ significant inflammatory cell migration was induced in our Ni allergy mouse model (Fig. 7e ). We also investigated whether Ni-DCs induce sensitization; however, Ni sensitization was not induced by s.c. injection of Ni-DCs ( Supplementary Fig. S5c ). These results indicated that Ni-DCs induced Ni allergy at the elicitation phase. www.nature.com/scientificreports www.nature.com/scientificreports/
Discussion
To induce Ni-specific T cell activation, Ni ions need to be presented by professional APCs: however, the DC subsets responsible for this have not yet been identified. In the present study, we used an Ni-specific fluorescent probe NPG and clearly demonstrated that migratory DCs exhibited strong Ni-binding capabilities in skin-draining and mandibular LNs, but not in mesenteric or medial iliac LNs. An i.d. injection of IL-1β induced the activation of LCs and dermal DCs, which exhibited stronger Ni-binding capabilities. Ni-binding LCs were detected in draining LNs after i.d. challenge with IL-1β and Ni. Moreover, the i.d. injection of Ni-DCs prepared from skin-draining LNs, but not mesenteric LNs, elicited Ni-allergic inflammation. Previous studies reported that the human B cell line Raji cells showed Ni binding on the cell surface 23, 29 . This is the first study to investigate the Ni-binding capabilities of DCs from various LNs.
Migratory DCs transport self and non-self Ags, which are captured in local tissues. On the other hand, resident DCs capture Ags that are incoming from blood and/or lymph flow 30 . Migratory DCs exhibited stronger Ni-binding capabilities than resident DCs in skin-draining and mandibular LNs. Skin and oral mucosa are considered to be the site at which Ni ions invade and are recognized by the host immune system. Ni-binding capabilities were significantly weaker in mesenteric and medial iliac LNs. It was reported that even contacts with Ni through intestinal mucosa by the ingestion of Ni-containing foods induce Ni-allergic dermatitis, also known as systemic contact dermatitis 31 . These results suggested that the Ni-binding capabilities of migratory DCs in draining LNs are important for establishing whether tissues have Ni-allergic responses.
We used 100 μM NiCl 2 for in vitro incubation with cells. Tanaka et al. reported that the elution of Ni ions from a metal wire was enhanced by inflammation 32 . They reported that approximately 100 nmol/g tissue of Ni ions was eluted from the metal wire implanted subcutaneously into the dorsum with injection of LPS into the site immediately after implantation. Murine macrophages stimulated with LPS eluted approximately 250 μM Ni ions from the Ni plate. Therefore, we considered that the concentration (100 μM) of NiCl 2 used in this study was suitable for the site of local inflammation.
Although we did not identify Ni-binding receptor(s) on migratory DCs, we noted some biochemical properties. Ni-binding capabilities were trypsin-resistant, reversible, and did not compete with other divalent cations, such as Ca 2+ , Mn 2+ , and Co 2+ . These results suggested that Ni binds to specific receptor(s), but not to general metal-binding sites.
Preincubation with anti-MHC class II mAbs did not affect ΔMFI. On the other hand, Ni-binding capabilities were significantly stronger in MHC class II hi cells. Not only the Ni-binding capabilities but also the expression levels of MHC class II were higher in migratory DCs in skin-draining and mandibular LNs than those in mesenteric LNs. MHC class II hi cells in local skin tissues showed stronger Ni-binding capabilities. Ags captured at local sites and presented on MHC molecules may be responsible for Ni-binding capabilities. However, histogram analysis showed that incubation with Ni induced a peak shift but not a NPG hi subpopulation. These results indicated that all migratory DCs, but not specific subpopulation(s), have Ni-binding capabilities. Further studies are needed to clarify whether MHC class II and Ag peptides on MHC molecules are involved in Ni-binding capabilities.
XCR1 + cDC1s exhibited strong Ni-binding capabilities. cDC1 has cross-presentation activities and activated CD8 + T cells 4 . CD8 + T cells play important roles in Pd allergy 12 , suggesting that the stronger Ni-binding capabilities of cDC1s effectively activated Ni-specific CD8 + T cells. XCR1 -cD11b + cDC2s also exhibited strong Ni-binding capabilities. cDC2s are major dermal DCs that migrate and transport Ags to draining LNs 33 . XCR1 -CD11b -DNcDCs are activated by TSLP in contact hypersensitivity 6 . Although TSLP induces Th2 cytokines, it plays a role in Th1-type Ni allergy 15 . DNcDCs with Ni-binding capabilities may contribute to the TSLP-dependent pathway of Ni allergy. LCs in skin-draining LNs also exhibited Ni-binding capabilities. Moreover, Ni-binding LCs were detected in draining LNs after in vivo challenge with IL-1β and Ni. LCs have been reported to induce Th17 responses 3 . Analyses with human samples revealed that Th17 were also induced in Ni allergy 14 . The Ni-binding capabilities of LCs may be involved in the induction of Th17.
An i.d. injection of IL-1β into ear pinnae activated epidermal LCs and dermal DCs with high expression levels of MHC class II. These MHC class II hi -LCs and dermal DCs exhibited stronger Ni-binding capabilities than non-activated, MHC class II int cells. In addition, the i.d. injection of IL-1β and Ni into ear pinnae induced Ni-binding LCs in draining LNs. IL-1 is a critical inflammatory cytokine of contact hypersensitivity 34, 35 . The Ni allergy mouse model used in this study depends on IL-1 24 . We reported previously that the adjuvant activity of resin monomers in Ni allergy was dependent on IL-1 36 . These findings suggested that the activation of LCs and dermal DCs with strong Ni-binding capabilities is one of the pathological roles of IL-1β in Ni allergy.
Stimulation with Ni induced the expression of IL-1 β mRNA in the pan-DC fraction from not only skin-draining LNs but also mesenteric LNs. Intracellular pro-IL-1β was also induced by Ni stimulation in skin-draining and mesenteric LN cells. This induction was only detected at a higher concentration (1,000 μM) of Ni. However, 100 μM Ni, a concentration that induced significant Ni binding in skin-draining LN cells, did not induce the expression of IL-1β. These results suggested that the expression of IL-1β is not induced by Ni binding. Ni activates some transcriptional factors that contribute to the expression of IL-1β [37] [38] [39] . Moreover, a Ni stimulation has been shown to activate MAP kinase kinase 6 in murine DCs 20 . Further studies are needed to clarify the induction mechanisms of IL-1β in Ni-stimulated DCs.
Donor cells were detected in auricular LNs of recipient mice after an i.d. injection of pan-DCs prepared from skin-draining and mesenteric LNs. We detected the expression of CCR7 on migratory DCs in skin-draining and mesenteric LNs. CCR7 is important for the migration of DCs to draining LNs from local tissues such as skin and gut 28 . Significant ear swelling was induced after the i.d. injection of Ni-DCs prepared from skin-draining LNs, but not those from mesenteric LNs, into the ear pinnae of Ni-sensitized mice. These results suggested that DCs with strong Ni-binding capabilities elicited Ni-allergic inflammation. A previous study reported that migratory DCs, particularly CD103 − cDC2s, have a short lifespan and die by apoptosis 2 d after migration 33 . Ags carried by migratory DCs are transferred to and presented by resident DCs 40 . Therefore, Ni-DCs may also die after migrating to draining LNs. Further studies are needed to clarify whether Ni-DCs directly activate Ni-specific T cells.
Our present results suggest novel therapeutic strategies for Ni allergy. Ni-binding receptor(s) may be a potential therapeutic target. Functional manipulation of Ni-binding DCs is also possible therapeutic approach. Moreover, appropriate targeting of migratory cDC2 in skin-draining and mandibular LNs may be useful for Ni-specific immunotherapy. Dermal CD11b + cDCs show aldehyde dehydrogenase activity, which is involved in retinoic acid production, and induce Foxp3 + Treg cells 41 . Retinoic acid is required the de novo generation of Foxp3 + Treg cells 8 . Foxp3latency-associated peptide + Treg cells are also induced by dermal CD11b + cDC2s 42 . Oral CD11b + cDCs also show aldehyde dehydrogenase activity and induce Foxp3 + Treg cells in mandibular LNs 9 . These findings suggested that Ni-binding cDC2s in the skin-draining and mandibular LNs can induce Ni-specific Treg cells.
In conclusion, the present study clearly demonstrated that migratory DCs in skin-draining and mandibular LNs exhibited Ni-binding capabilities. Ni-treated DCs purified from skin-draining LNs elicited Ni-allergic inflammation. However, there are still unresolved questions regarding Ni-binding receptor(s) and the mechanisms by which Ni-DCs elicit Ni-allergic inflammation. The elucidation of these questions will be of value for the development of effective methods to prevent and treat metal allergies.
Materials and Methods
Mice. Female C57BL/6 N CD45.2 + mice were purchased from CLEA Japan (Tokyo, Japan). Congenic C57BL/6 CD45.1 + mice were provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan. The nomenclature of LNs was in accordance with that reported previously 43 . Superficial parotid (auricular), proper axillary, accessory axillary, and subiliac (inguinal) LNs were pooled and used as skin-draining LNs. Jejunal LNs were used as mesenteric LNs. All animal procedures were approved by the Institutional Animal Care and Use Committee of Tohoku University (approved number: 2016DnA-054) and the Genetic Modification Safety Committee of Tohoku University (approved number: 2016DnLMO-020), and were performed in accordance with their guidelines.
LN cell preparation.
LNs were minced and incubated with 1 mg/ml collagenase D (Roche, Basel, Switzerland) and 5 μg/ml DNase (SIGMA-Aldrich, St Louis, MO) in DMEM containing 10% FCS at 37 °C for 30 min with shaking. Cells were filtered using a 70-μm cell strainer.
To analyze draining LNs after in vivo challenge, ear pinnae of naïve mice were i.d. challenged (20 μl/ear) 5 times every 24 h with 50 ng of IL-1β (BioLegend, San Diego, CA) in the presence (left pinna) or absence (right pinna) of 10 mM NiCl 2 . Twenty-four hours after the last challenge, auricular LNs were harvested, and LN cells were prepared without enzymatic treatment.
Ear cell preparation. Ear pinnae were i.d. injected (20 μl/ear) with 50 ng of IL-1β or PBS containing 2.5% FCS and collected 24 h after the injection. Ear pinnae were split along with cartilage and incubated with 0.25% trypsin and 1 mM EDTA (Nacalai Tesque, Kyoto, Japan) at 37 °C for 1 h. After separating the epidermis and dermis, epidermal cells were prepared by pipetting. The dermis was minced and incubated with 1 mg/ml type-IV collagenase (SIGMA-Aldrich) and 0.1 mg/ml DNase in DMEM containing 10% FCS at 37 °C for 2 h with shaking. Cells were filtered using a 70-μm cell strainer. To analyze inflammatory cell infiltration, ear pinnae from the Ni allergy mouse were minced and incubated with 1 mg/ml type-IV collagenase and 0.1 mg/ml DNase in DMEM containing 10% FCS at 37 °C for 2 h with shaking. Cells were filtered using a 70-μm cell strainer.
Flow cytometry. Cells were incubated with 100 μl of NiCl 2 in PBS containing 0.01% FCS at 37 °C for the indicated time. After washing with PBS, cells were further incubated with 100 μl of NPG-DCF dipotassium salt (1 μM in PBS, Thermo Fisher Scientific, Waltham, MA) for 30 min. In some experiments, cells were treated with 1 mM EDTA-PBS at 37 °C for 30 min before staining with NPG. Cells were incubated with anti-CD16/32 (2.4G2, produced in-house) to block of non-specific binding, then stained with antibodies. The antibodies used were listed in Supplementary Table S1 . To analyze the neutralizing effects of anti-MHC class II Abs, cells were preincubated with antibodies for 20 min on ice before incubation with Ni and NPG. Regarding intracellular cytokine staining, cells were fixed with Cytofix/Cytoperm (BD Biosciences, San Jose, CA) and washed with Perm Wash Buffer (BioLegend). Dead cells were stained with DAPI for extracellular staining or Zombie Yellow (BioLegend) for intracellular cytokine staining and excluded. Data were acquired on an LSRFortessa cell analyzer (BD Biosciences) and analyzed using FlowJo software (Tree Star, Ashland, OR). Geometrical mean fluorescence intensity was shown as mean fluorescence intensity (MFI). The results of Ni-NPG staining are shown as delta MFI (ΔMFI), calculated as [MFI Ni 100 μM -MFI Ni 0 μM ].
Trypsin treatment of LN cells. LN cells were incubated with 100 μl of 0.25% Trypsin-1 mM EDTA solution for the indicated time. To stop trypsin digestion, 1 ml of 10% FCS-PBS was added. After incubation on ice for 5 min, the cells were stained for flow cytometric analyses.
In vivo FMS-like tyrosine kinase 3 ligand treatment.
To expand DCs in vivo, mice were s.c. injected B16-Flt3L, which were provided by Dr. A. Kumanogoh (Osaka University, Osaka, Japan). Flt3L is a cytokine that induces DC development 27 . B16-Flt3L cells were grown in DMEM containing 10% FCS. A total of 2 × 10 6 cells/200 μl were s.c. injected into the dorsal region of mice. Mice were killed and tissues were collected 2 weeks after the injection.
Pan-DC enrichment. The pan-DC fraction was prepared by negative selection using the EasySep Mouse Pan-DC Enrichment Kit (STEMCELL Technologies, Vancouver, BC, Canada) as described in the instruction manual.
www.nature.com/scientificreports www.nature.com/scientificreports/ In vitro stimulation assay. Cells (1 × 10 6 cells/ml) were suspended in RPMI1640 containing 10% FCS, 1 mM sodium pyruvate and 50 μM 2-mercaptoethanol and stimulated with LPS (1 μg/ml) or NiCl 2 (1,000 or 100 μM) for 4 h. Cells were collected and analyzed by quantitative RT-PCR. In intracellular cytokine staining, cells were washed and incubated further without any stimulation for 20 h.
Quantitative RT-PCR. Cells were homogenized in ISOGEN II (Nippon Gene, Tokyo, Japan) and total RNA was extracted as described by the manufacturer. Complement DNA (cDNA) was synthesized using a Transcriptor First Strand cDNA Synthesis Kit (Roche). Quantitative RT-PCR was performed using the SYBR Select Master Mix and StepOnePlus realtime PCR system (Applied Biosystems, Waltham, MA). The primers used for quantitative RT-PCR were listed in Supplementary Table S2 . mRNA expression levels were calculated by the ΔΔCT method using β-actin as an inner control. Ni allergy mouse model. Pan-DCs (1 × 10 6 cells) were incubated with 100 μl of 100 μM NiCl 2 in PBS containing 0.01% FCS at 37 °C for 60 min. After washing with PBS, the cells were suspended in saline and referred to as Ni-DCs. The pan-DCs incubated without Ni were referred to as PBS-DCs. A Ni allergy mouse model was constructed as previously reported 24 . Briefly, mice were sensitized with an intraperitoneal (i.p.) injection of solution containing 0.5 mM NiCl 2 and 0.5 μg/ml LPS. Two weeks after sensitization, mice were challenged with 20 μl of NiCl 2 or the pan-DC fraction by an i.d. injection into both pinnae. Ear swelling was measured 48 h after the challenge using the Peacock dial thickness gauge. Inflammatory cell migration was analyzed by flow cytometry.
Statistical analysis.
Experimental values were given as the mean ± SD. Statistical analyses were performed with a one-or two-way ANOVA using Tukey's, Dunnett's, and Sidak's multiple comparisons tests and an unpaired two-tailed t-test (GraphPad Prism version 7.02, GraphPad Software, San Diego, CA). P < 0.05 was considered to be significant. Data shown are representative of at least two independent experiments.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
